From 764.29$

rituximab

CD20 monoclonal antibodies

Scoring is done by our AI based assistant on the data from the FDA and other sources

6.5

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

5.5

Zevalin Y-90 (Intravenous)

5.5

Glofitamab-gxbm (Intravenous)

5.5

Hyaluronidase and rituximab

5.5

Riabni (Intravenous)

5.5

Rituximab and hyaluronidase human, recombinant (Subcutaneous)

5.5

Rituximab-arrx (Intravenous)

5.3

Ruxience (Intravenous)

5.2

Ocrevus

5.2

Truxima

4.8

Rituximab-pvvr (Intravenous)

4.7

Arzerra

4.6

Ruxience (Intravenous)

4.2

Ofatumumab

4.1

Riabni (Intravenous)